Topics

Bristol Myers investors breathe easier as multiple sclerosis drug approved by FDA

05:00 EDT 26 Mar 2020 | BioPharmaDive

Regulatory clearance for Zeposia is the first of three drug approval milestones that must be met for former Celgene shareholders to see the full value of the 2019 acquisition.

Original Article: Bristol Myers investors breathe easier as multiple sclerosis drug approved by FDA

NEXT ARTICLE

More From BioPortfolio on "Bristol Myers investors breathe easier as multiple sclerosis drug approved by FDA"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...